Relay Therapeutics, Inc. — All Filings
487 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
424B7
5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
PRE 14A
S-1
S-1/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0000950170-25-083311 | Jun 6, 2025 | — |
| 4 | 4 | 0000950170-25-083312 | Jun 6, 2025 | — |
| 4 | 4 | 0000950170-25-083310 | Jun 6, 2025 | — |
| 8-K | 8-K | 0001193125-25-137162 | Jun 6, 2025 | — |
| 8-K | 8-K | 0001193125-25-134908 | Jun 4, 2025 | Jun 3, 2025 |
| SCHEDULE 13G | — | 0001641172-25-010853 | May 15, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-063553 | May 5, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-063539 | May 5, 2025 | — |
| SCHEDULE 13G/A | — | 0000932471-25-000558 | Apr 30, 2025 | — |
| 4 | 4 | 0000950170-25-061364 | Apr 30, 2025 | Apr 28, 2025 |
| 4 | 4 | 0000950170-25-061365 | Apr 30, 2025 | Apr 28, 2025 |
| 4 | 4 | 0000950170-25-061366 | Apr 30, 2025 | Apr 28, 2025 |
| 4 | 4 | 0000950170-25-061367 | Apr 30, 2025 | Apr 28, 2025 |
| 144 | — | 0001950047-25-002594 | Apr 29, 2025 | — |
| 144 | — | 0001950047-25-002580 | Apr 28, 2025 | — |
| 4 | 4 | 0000950170-25-057996 | Apr 24, 2025 | Apr 23, 2025 |
| ARS | ARS | 0000950170-25-057381 | Apr 23, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0000950170-25-057333 | Apr 23, 2025 | Jun 6, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-057350 | Apr 23, 2025 | — |
| SCHEDULE 13G/A | — | 0001576419-25-000649 | Apr 17, 2025 | — |
| 4 | 4 | 0000950170-25-047762 | Mar 31, 2025 | Mar 27, 2025 |
| 4 | 4 | 0000950170-25-047743 | Mar 31, 2025 | Mar 27, 2025 |
| 4 | 4 | 0000950170-25-047717 | Mar 31, 2025 | Mar 27, 2025 |
| 4 | 4 | 0000950170-25-047725 | Mar 31, 2025 | Mar 27, 2025 |
| 144 | — | 0001950047-25-002214 | Mar 27, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-001532 | Mar 20, 2025 | — |
| S-8 | S-8 | 0000950170-25-027812 | Feb 26, 2025 | — |
| 8-K | 8-K | 0000950170-25-027733 | Feb 26, 2025 | — |
| 10-K | 10-K | 0000950170-25-027756 | Feb 26, 2025 | Dec 31, 2024 |
| 4 | 4 | 0000950170-25-020272 | Feb 13, 2025 | Feb 11, 2025 |
| SCHEDULE 13G/A | — | 0002012383-25-001239 | Feb 5, 2025 | — |
| 4 | 4 | 0000950170-25-011319 | Jan 30, 2025 | Jan 28, 2025 |
| 4 | 4 | 0000950170-25-011327 | Jan 30, 2025 | Jan 28, 2025 |
| 4 | 4 | 0000950170-25-011311 | Jan 30, 2025 | Jan 28, 2025 |
| 4 | 4 | 0000950170-25-011335 | Jan 30, 2025 | Jan 28, 2025 |
| 144 | — | 0001950047-25-000469 | Jan 29, 2025 | — |
| 144 | — | 0001950047-25-000463 | Jan 28, 2025 | — |
| 144 | — | 0001950047-25-000394 | Jan 23, 2025 | — |
| 4 | 4 | 0000950170-25-008451 | Jan 23, 2025 | Jan 21, 2025 |
| 144 | — | 0001950047-25-000375 | Jan 22, 2025 | — |
| 144 | — | 0001950047-25-000342 | Jan 21, 2025 | — |
| 4 | 4 | 0000950170-25-005564 | Jan 14, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-005565 | Jan 14, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-005566 | Jan 14, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-005567 | Jan 14, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-005568 | Jan 14, 2025 | Jan 10, 2025 |
| 8-K | 8-K | 0000950170-25-004586 | Jan 13, 2025 | — |
| 144 | — | 0001950047-25-000115 | Jan 6, 2025 | — |
| 4 | 4 | 0000950170-25-002500 | Jan 6, 2025 | Jan 2, 2025 |
| 144 | — | 0001950047-25-000085 | Jan 3, 2025 | — |